Finansal Hizmetler

Total Market Cap 6,477.2B
P/E (Weighted)Price to Earnings ratio. 11.09 Medyan: 6.85
P/B (Weighted)Price to Book ratio. 0.87 Medyan: 0.47
P/E (Arithmetic)Simple average P/E. 15.74
Avg Lothien ScoreFinancial health score (0-100). 65
Avg DamodaranDamodaran scoring model. 47
Avg PotentialExpected upside potential %. +42.4%
Avg Dalio ScoreDalio debt cycle score. 73
Distributions
Lothien Distribution
0–25
0
25–40
8
40–55
21
55–70
15
70–100
42
Damodaran Distribution
0–25
13
25–40
14
40–55
28
55–70
22
70–100
9
Upside Potential
-100% – -20%
12
-20% – +0%
9
+0% – +20%
11
+20% – +50%
20
+50%+
34

Data date 2026-10-16 Not investment advice; the figures are rule-based model output. How the scores are computed

Score record
Data date 2026-10-16
Update frequency Scheduled analysis run on business days at 19:30 Istanbul time; not every symbol is refreshed in every run

Method summaryThe Lothien Robustness Score (0-100) is a weighted combination of sub-scores computed by fixed rules from published financial statements and price data (Damodaran valuation, Dalio risk, Piotroski F-score, earnings quality, momentum and others). The rules are applied automatically to every covered stock, with weights that vary by sector.

AssumptionsCalculations rest on the company's latest published financial statements and on price data that may be delayed. Where four quarters have not been published, annual figures may be scaled from the available quarters. Model parameters such as the risk-free rate, the risk premium and long-term growth are fixed assumptions per exchange and contain no company-specific expectation.

Conflict of interestNo statement has been published on whether MIDAK, the operator of Lothien, or its team hold positions in these stocks. The figures are produced automatically by the same rules, without regard to any such position.

WarningThis information is not within the scope of investment advisory services and is not investment advice. The figures are the output of rule-based models and may not suit your financial situation or your risk and return preferences. Making an investment decision on the basis of this information alone may not lead to results that meet your expectations.

Model output; not investment advice; different models can disagree. Report an error

Stocks in Sector
Stock PriceCurrent trading price. Market CapTotal market capitalization. FKPrice to Earnings ratio. PD/DDPrice to Book ratio. EV/EBITDAEnterprise Value / EBITDA. ROICReturn on Invested Capital. WACCWeighted Average Cost of Capital (WACC). PUSLAFinancial health score (0-100). DamodaranValuation score. Intrinsic ValueFair value via DCF model. Potential %Expected upside potential %. Dalio RiskDalio Debt Cycle Score Debt/EquityDebt to Equity ratio.
0966
17.53 63.0B 2.33 0.57 0.44 — — 90 81 46.62 +124.5% 97 0.71
1578
2.02 12.3B 1.54 0.15 2.09 — — 89 66 6.06 +150.0% 93 1.99
1336
42.26 131.8B 3.22 0.91 0.58 — — 89 82 106.22 +113.5% 93 0.17
3866
4.86 28.3B 2.48 0.46 1.95 — — 89 75 13.28 +129.8% 90 2.10
2669
3.33 10.9B 3.91 1.50 1.28 — — 88 82 7.07 +84.1% 89 0.02
6199
0.93 13.6B 2.87 0.22 2.52 — — 86 59 2.59 +134.4% 95 1.74
3698
4.72 65.6B 3.37 0.33 2.30 — — 84 68 13.14 +133.7% 86 2.23
6196
0.85 7.7B 3.47 0.12 3.23 — — 83 53 2.13 +112.9% 93 2.01
1963
8.31 30.1B 4.46 0.38 3.29 — — 83 61 18.93 +95.9% 93 2.56
2799
0.58 46.5B 3.57 0.64 — — — 83 75 1.36 +100.0% 92 15.35
3660
23.18 5.6B 1.28 0.19 0.18 — — 83 73 69.54 +150.0% 85 0.12
1508
1.22 51.8B 4.52 0.39 0.79 — — 82 59 2.78 +95.9% 94 0.12
1216
0.28 10.2B 2.43 0.09 — — — 81 59 0.78 +132.1% 95 0.97
2016
2.45 67.3B 4.43 0.28 2.82 — — 81 51 5.72 +100.0% 94 2.54
6963
3.47 39.9B 5.38 0.58 1.12 — — 81 62 6.99 +76.1% 92 0.35
9668
0.72 12.8B 1.98 0.09 3.42 — — 81 60 1.92 +125.0% 95 2.67
6099
13.73 119.4B 5.42 0.70 — — — 80 64 22.58 +47.7% 92 1.61
6806
2.38 59.6B 5.28 0.44 — — — 80 53 4.29 +59.2% 94 1.89
1606
1.52 19.2B 3.25 0.37 14.98 — — 80 69 3.36 +90.8% 63 8.35
0267
12.70 369.4B 1.51 0.39 4.17 — — 79 76 31.98 +113.9% 58 3.28
0998
8.53 474.7B 5.55 0.47 1.09 — — 79 60 17.68 +80.4% 82 1.43
6066
11.16 86.6B 3.81 0.59 11.10 — — 79 72 20.58 +60.7% 58 1.77
6886
16.23 146.5B 6.11 0.58 — — — 79 55 25.21 +41.0% 94 1.53
1776
16.77 131.2B 5.82 0.63 — — — 78 60 27.54 +47.5% 87 1.64
2666
4.59 9.2B 3.56 0.38 15.09 — — 78 64 9.04 +69.7% 59 2.52
9677
3.06 18.3B 6.91 0.47 1.01 — — 78 44 5.54 +58.2% 95 1.48
9889
3.06 21.1B 4.65 0.30 2.85 — — 78 50 6.94 +95.1% 81 1.91
1988
3.34 146.2B 4.34 0.18 1.10 — — 76 51 8.18 +108.7% 70 1.26
3618
6.55 74.4B 5.22 0.46 — — — 76 55 11.62 +57.2% 86 1.39
6049
27.00 14.9B 8.20 1.20 0.86 — — 76 56 41.03 +39.0% 85 0.01
6178
6.88 31.7B 6.19 0.36 — — — 76 41 11.26 +40.7% 93 1.06
1456
3.51 19.9B 4.30 0.32 18.26 — — 76 48 6.45 +56.1% 58 1.50
3360
6.16 29.3B 1.85 0.47 21.52 — — 76 73 12.79 +77.4% 47 5.04
3958
5.88 50.0B 6.34 0.50 — — — 75 51 9.48 +45.2% 85 1.53
6818
2.81 166.0B 5.17 0.23 3.34 — — 75 53 6.16 +89.3% 68 2.30
2611
14.53 256.1B 6.30 0.59 — — — 74 49 20.44 +28.1% 91 1.45
2356
13.92 19.6B 7.90 0.55 0.04 — — 73 41 23.24 +48.2% 93 0.12
6030
23.26 344.7B 7.30 0.84 — — — 73 56 29.65 +20.3% 94 0.96
0440
43.44 13.9B 6.75 0.37 — — — 72 37 67.25 +35.1% 93 0.12
1658
5.54 665.3B 6.48 0.49 — — — 72 53 8.33 +37.2% 94 0.23
1359
0.89 34.0B 8.11 0.15 11.84 — — 72 47 1.37 +39.3% 83 4.68
0363
13.57 14.8B 7.30 0.29 6.27 — — 71 35 21.26 +40.8% 84 1.11
2378
93.50 233.2B 9.08 1.50 9.69 — — 69 66 93.36 -0.1% 95 0.27
2691
5.82 5.8B 7.07 0.84 — — — 68 51 7.12 +16.5% 94 0.23
1551
1.49 21.5B 8.61 0.19 — — — 68 42 2.56 +49.7% 92 1.76
1375
1.51 7.0B 9.23 0.41 — — — 67 28 1.98 +19.9% 92 0.94
9636
26.90 12.6B 11.63 3.61 7.51 — — 64 60 21.21 -15.9% 98 0.00
2869
4.09 12.7B 12.31 1.36 3.36 — — 64 41 4.51 +7.6% 75 0.06
2596
2.64 12.1B 18.39 0.91 0.25 — — 63 24 3.15 +14.0% 95 0.38
1908
12.89 29.1B 6.79 0.59 5.60 — — 63 51 17.53 +27.0% 68 1.92
0010
11.89 16.2B 11.82 0.16 12.58 — — 62 44 16.49 +27.8% 61 0.56
2007
0.17 8.0B 0.69 — — — — 62 56 0.51 +94.1% 28 —
3908
19.56 94.4B 8.20 0.66 15.07 — — 61 47 20.23 +2.4% 62 2.70
6098
5.03 16.3B 23.00 0.38 1.15 — — 58 29 7.73 +38.8% 66 0.08
0683
17.55 25.4B 27.05 0.24 16.59 — — 56 35 19.99 +10.0% 63 0.53
0014
15.71 16.1B 25.72 0.22 14.69 — — 56 37 18.89 +13.6% 44 0.37
6666
1.21 13.1B 11.28 6.94 4.72 — — 56 52 1.01 -12.4% 82 0.06
0165
5.71 9.6B — 0.35 — — — 54 30 13.86 +61.3% 44 1.08
2588
67.25 46.7B 9.00 0.85 16.35 — — 53 48 59.39 -7.8% 48 2.63
2202
2.38 28.4B — 0.24 — — — 53 56 7.14 +95.8% 31 3.27
2778
2.14 13.2B — 0.33 — — — 53 39 5.39 +65.4% 31 0.36
0817
1.23 16.6B 11.28 0.27 14.51 — — 52 36 1.59 +19.5% 45 2.44
1528
0.99 4.3B — 0.15 — — — 52 55 2.97 +96.0% 18 1.80
0945
339.60 564.4B 15.24 1.92 11.55 — — 51 49 220.43 -26.3% 89 0.27
2888
221.00 483.8B 11.20 1.11 8.76 — — 51 53 204.36 -5.4% 46 2.04
1030
1.34 9.7B 20.98 0.18 8.47 — — 51 42 1.79 +22.4% 49 1.23
1209
38.78 88.5B 18.97 4.87 12.40 — — 51 54 20.70 -35.0% 88 0.14
0004
19.23 58.8B 100.00 0.40 73.24 — — 46 16 14.90 -16.2% 68 0.12
1997
30.48 92.5B — 0.51 — — — 46 33 51.31 +29.4% 30 0.19
0960
4.75 32.8B 27.28 0.17 26.74 — — 46 41 5.53 +11.2% 48 1.02
1428
6.09 10.3B 15.42 4.76 15.43 — — 46 52 3.21 -35.5% 74 2.27
2602
19.00 22.1B 27.13 1.29 3.84 — — 46 24 15.64 -12.7% 65 0.02
1972
24.42 140.6B 41.62 0.52 17.07 — — 45 19 16.60 -23.1% 63 0.18
0123
3.16 12.7B 100.00 0.20 18.47 — — 44 35 3.58 +8.9% 46 1.92
1828
30.86 39.5B 30.32 0.81 20.77 — — 44 21 15.81 -35.1% 87 0.52
2423
45.40 143.8B 26.00 1.87 15.39 — — 44 26 19.74 -42.4% 76 0.22
1918
0.56 11.2B — 0.28 76.92 — — 44 28 0.87 +28.6% 24 5.53
3396
17.64 41.6B 33.33 0.61 4.34 — — 42 22 16.88 -2.9% 45 2.99
0622
3.02 21.0B 100.00 6.73 107.94 — — 40 12 0.76 -56.3% 84 0.02
3900
5.84 14.8B 100.00 0.36 11.22 — — 39 24 5.60 -2.7% 48 3.80
0656
4.88 39.4B — 0.36 102.44 — — 39 27 6.02 +11.9% 21 2.67
1788
2.87 27.4B 20.33 1.72 29.62 — — 33 24 1.20 -41.8% 50 6.33
3887
1.95 5.4B — 1.91 — — — 29 18 0.83 -24.6% 57 0.01
0290
1.49 15.4B — 2.21 — — — 28 11 0.52 -30.9% 75 0.08
0863
10.25 9.2B — 2.81 — — — 28 4 3.06 -33.7% 70 0.00
1396
10.41 16.5B 100.00 3.18 44.21 — — 28 10 2.66 -53.6% 44 1.21

The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.